Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs

Condition:   COVID-19 Pneumonia Interventions:   Procedure: Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells;   Drug: Antibiotics;   Drug: Hormones;   Drug: Anticoagulant Therapy;   Device: Оxygen therapy Sponsors:   Institute of Cell Therapy;   Kyiv City Clinical Hospital # 4 Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials